Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
4.02
Dollar change
+0.01
Percentage change
0.25
%
Index- P/E- EPS (ttm)-26.08 Insider Own56.24% Shs Outstand5.75M Perf Week-8.84%
Market Cap43.17M Forward P/E- EPS next Y-1.40 Insider Trans31.16% Shs Float4.70M Perf Month18.58%
Income-34.36M PEG- EPS next Q-0.68 Inst Own11.77% Short Float0.79% Perf Quarter-5.78%
Sales0.00M P/S- EPS this Y70.30% Inst Trans1.58% Short Ratio1.55 Perf Half Y82.73%
Book/sh1.42 P/B2.84 EPS next Y38.46% ROA-132.51% Short Interest0.04M Perf Year81.90%
Cash/sh1.05 P/C3.84 EPS next 5Y- ROE-155.72% 52W Range1.75 - 8.59 Perf YTD40.56%
Dividend Est.- P/FCF- EPS past 5Y19.56% ROI-421.20% 52W High-53.20% Beta1.51
Dividend TTM- Quick Ratio2.88 Sales past 5Y0.00% Gross Margin- 52W Low129.71% ATR (14)0.30
Dividend Ex-Date- Current Ratio2.88 EPS Y/Y TTM-12.44% Oper. Margin0.00% RSI (14)42.07 Volatility4.09% 6.81%
Employees14 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price16.38
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q84.94% Payout- Rel Volume0.07 Prev Close4.01
Sales Surprise- EPS Surprise17.48% Sales Q/Q- EarningsMar 28 BMO Avg Volume23.97K Price4.02
SMA20-3.75% SMA50-9.07% SMA20010.55% Trades Volume1,756 Change0.25%
Apr-10-24 03:30PM
Mar-28-24 11:53AM
07:00AM
Mar-13-24 08:00AM
Feb-28-24 06:57PM
08:00AM Loading…
Feb-13-24 08:00AM
Feb-07-24 04:05PM
Jan-22-24 08:00AM
Dec-11-23 07:30AM
Nov-09-23 07:00AM
Nov-02-23 09:15AM
Sep-06-23 07:30AM
Aug-31-23 07:30AM
Aug-11-23 07:01AM
Aug-10-23 04:05PM
06:24AM Loading…
06:24AM
Aug-09-23 07:30AM
06:26AM
Aug-08-23 06:28AM
Aug-07-23 06:35AM
Aug-04-23 07:14AM
Aug-03-23 07:15AM
Aug-02-23 07:52AM
Aug-01-23 06:51AM
Jul-31-23 06:44AM
Jul-28-23 07:58AM
Jul-27-23 07:10AM
Jul-26-23 01:12PM
Jul-25-23 07:16AM
Jul-24-23 07:12AM
07:23AM Loading…
Jul-21-23 07:23AM
Jul-20-23 06:55AM
Jul-19-23 07:10AM
Jul-18-23 06:53AM
Jul-17-23 07:10AM
Jul-14-23 06:50AM
Jul-13-23 07:02AM
Jul-12-23 07:22AM
Jul-11-23 06:08AM
Jul-10-23 06:56AM
Jul-05-23 06:46AM
Jul-03-23 06:50AM
Jun-30-23 06:52AM
Jun-29-23 06:49AM
Jun-28-23 06:58AM
Jun-27-23 06:46AM
Jun-26-23 06:41AM
Jun-23-23 09:24AM
Jun-12-23 07:30AM
Jun-06-23 07:30AM
May-23-23 07:30AM
May-15-23 08:55AM
Mar-29-23 07:53PM
CalciMedica, Inc. operates as a biopharmaceutical company. It focuses on developing therapies for life-threatening inflammatory diseases. The firm's product candidate Auxora helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Roberts Eric WCHIEF BUSINESS OFFICERApr 02 '24Buy3.903,25412,69139,894Apr 02 08:33 PM
Roberts Eric WCHIEF BUSINESS OFFICERApr 01 '24Buy3.907462,90936,640Apr 02 08:33 PM
MIDDLETON FRED ADirectorJan 23 '24Buy3.70679,3842,515,080946,744Jan 25 08:00 PM
Sanderling Venture Partners VI10% OwnerJan 23 '24Buy3.70436,0281,614,176727,433Jan 25 08:00 PM
Sanderling Venture Partners VI10% OwnerJan 23 '24Buy3.70243,356900,904946,744Jan 25 08:00 PM
WILSON ROBERT NDirectorDec 11 '23Buy3.305061,670182,161Dec 13 08:45 PM
Leheny A. RachelChief Executive OfficerNov 07 '23Buy3.342,0006,68018,840Nov 08 08:42 PM
Leheny A. RachelChief Executive OfficerNov 06 '23Buy3.122,4407,61516,840Nov 07 06:09 PM
Roberts Eric WChief Business OfficerNov 06 '23Buy3.122,4007,48835,894Nov 08 08:41 PM
Hebbar SudarshanChief Medical OfficerNov 03 '23Buy2.7436,00098,60046,000Nov 07 06:08 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.8311,24931,84633,494Nov 07 08:42 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.705,86015,82822,245Nov 06 06:40 PM
Leheny A. RachelChief Executive OfficerNov 03 '23Buy2.855,00014,25014,400Nov 06 06:39 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.773,70010,24920,287Nov 07 08:42 PM
Roberts Eric WChief Business OfficerNov 03 '23Buy2.803,2008,96016,587Nov 06 06:40 PM
Roberts Eric WChief Business OfficerAug 25 '23Buy3.187362,3405,000Aug 29 07:34 PM
Roberts Eric WChief Business OfficerAug 22 '23Buy3.277142,3354,264Aug 23 06:02 PM
Roberts Eric WChief Business OfficerAug 21 '23Buy3.251,7505,6883,550Aug 23 06:02 PM
Roberts Eric WChief Business OfficerJun 26 '23Buy3.701,2004,44113,387Jun 26 08:33 PM
Roberts Eric WChief Business OfficerJun 26 '23Buy3.5320070616,385Jun 26 08:33 PM
Roberts Eric WChief Business OfficerJun 23 '23Buy3.355001,67516,185Jun 26 08:33 PM